Literature DB >> 29494806

Synaptic vesicle cycle and amyloid β: Biting the hand that feeds.

Saak V Ovsepian1, Valerie B O'Leary2, Laszlo Zaborszky3, Vasilis Ntziachristos4, J Oliver Dolly5.   

Abstract

The synaptic vesicle cycle (SVC) holds center stage in the biology of presynaptic terminals. Through recurrent exocytosis and endocytosis, it facilitates a sequence of events enabling chemical neurotransmission between functionally related neurons. As a fundamental process that links the interior of nerve cells with their environment, the SVC is also critical for signaling and provides an entry route for a range of pathogens and toxins, enabling detrimental effects. In Alzheimer's disease, the SVC is both the prime site of amyloid β production and toxicity. In this study, we discuss the emerging evidence for physiological and pathological effects of Aβ on various stages of the SVC, from postfusion membrane recovery to trafficking, docking, and priming of vesicles for fusion and transmitter release. Understanding of the mechanisms of Aβ interaction with the SVC within the unifying calcium hypothesis of aging and Alzheimer's disease should further elucidate the fundamental biology of the presynaptic terminal and reveal novel therapeutic targets for Alzheimer's disease and other age-related dementias.
Copyright © 2018 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amyloid β; Exocytosis; Neuromodulation; Presynaptic terminal; SNARE complex; Transmitter release

Mesh:

Substances:

Year:  2018        PMID: 29494806     DOI: 10.1016/j.jalz.2018.01.011

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  22 in total

Review 1.  A Close Look at BACE1 Inhibitors for Alzheimer's Disease Treatment.

Authors:  Brati Das; Riqiang Yan
Journal:  CNS Drugs       Date:  2019-03       Impact factor: 5.749

2.  Proteomic identification of select protein variants of the SNARE interactome associated with cognitive reserve in a large community sample.

Authors:  Alfredo Ramos-Miguel; Andrea A Jones; Vladislav A Petyuk; Vilte E Barakauskas; Alasdair M Barr; Sue E Leurgans; Philip L De Jager; Kaitlin B Casaletto; Julie A Schneider; David A Bennett; William G Honer
Journal:  Acta Neuropathol       Date:  2021-03-01       Impact factor: 17.088

3.  Amyloid Plaques of Alzheimer's Disease as Hotspots of Glutamatergic Activity.

Authors:  Saak V Ovsepian; Valerie B O'Leary; Laszlo Zaborszky; Vasilis Ntziachristos; J Oliver Dolly
Journal:  Neuroscientist       Date:  2018-07-27       Impact factor: 7.519

4.  CYP46A1 Activation by Efavirenz Leads to Behavioral Improvement without Significant Changes in Amyloid Plaque Load in the Brain of 5XFAD Mice.

Authors:  Alexey M Petrov; Morrie Lam; Natalia Mast; Jean Moon; Yong Li; Erin Maxfield; Irina A Pikuleva
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

5.  Can Arginase Inhibitors Be the Answer to Therapeutic Challenges in Alzheimer's Disease?

Authors:  Saak Victor Ovsepian; Valerie Bríd O'Leary
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

6.  Pulse-Chase Proteomics of the App Knockin Mouse Models of Alzheimer's Disease Reveals that Synaptic Dysfunction Originates in Presynaptic Terminals.

Authors:  Timothy J Hark; Nalini R Rao; Charlotte Castillon; Tamara Basta; Samuel Smukowski; Huan Bao; Arun Upadhyay; Ewa Bomba-Warczak; Toshihiro Nomura; Eileen T O'Toole; Garry P Morgan; Laith Ali; Takashi Saito; Christelle Guillermier; Takaomi C Saido; Matthew L Steinhauser; Michael H B Stowell; Edwin R Chapman; Anis Contractor; Jeffrey N Savas
Journal:  Cell Syst       Date:  2020-12-15       Impact factor: 10.304

Review 7.  Integrated phylogeny of the human brain and pathobiology of Alzheimer's disease: A unifying hypothesis.

Authors:  Saak V Ovsepian; Valerie B O'Leary; Cyril Hoschl; Laszlo Zaborszky
Journal:  Neurosci Lett       Date:  2021-04-20       Impact factor: 3.197

Review 8.  Mitochondrial Bioenergetics and Dynamics in Secretion Processes.

Authors:  Jennyfer Martínez; Inés Marmisolle; Doménica Tarallo; Celia Quijano
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-22       Impact factor: 5.555

Review 9.  Retromer in Synaptic Function and Pathology.

Authors:  Lennart Brodin; Oleg Shupliakov
Journal:  Front Synaptic Neurosci       Date:  2018-10-24

10.  Depletion of acetate-producing bacteria from the gut microbiota facilitates cognitive impairment through the gut-brain neural mechanism in diabetic mice.

Authors:  Hong Zheng; Pengtao Xu; Qiaoying Jiang; Qingqing Xu; Yafei Zheng; Junjie Yan; Hui Ji; Jie Ning; Xi Zhang; Chen Li; Limin Zhang; Yuping Li; Xiaokui Li; Weihong Song; Hongchang Gao
Journal:  Microbiome       Date:  2021-06-25       Impact factor: 14.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.